Promedica International (PMI) leverages advanced clinical information technology to enhance the efficiency and effectiveness of clinical trials. Their scalable software and hardware capabilities are tailored to meet diverse client needs, ensuring that data processing and information management are optimized for various clinical research projects. PMI employs web-enabled technologies, including electronic Clinical Data Management (eCDM) applications, which facilitate rapid clinical database design, real-time query development, and 24/7 data access for users. This infrastructure supports timely data entry, monitoring, and resolution of queries, all while maintaining a secure environment through collaborative web portals.

In addition to their robust data management systems, PMI emphasizes the importance of biostatistics and clinical programming throughout the clinical study process. Their experienced team provides comprehensive support, from pre-study planning—such as statistical design input and sample size analysis—to ongoing data review during trials and final statistical analysis post-study. PMI's commitment to quality is underscored by their adherence to regulatory standards, including 21 CFR Part 11, and their ISO-certified Quality Management System, which ensures that all statistical outputs are accurate and reliable. This meticulous approach not only enhances the integrity of clinical research but also fosters strong partnerships with clients, as evidenced by high satisfaction ratings and repeat business.

United States

Promedica International is a privately held, full service CRO providing clinical trials for the medical device, biotechnology and pharmaceutical industries.  Founded in 1985, Promedica International, a woman-owned corporation, is headquartered in Orange County, California.  We have successfully been providing exceptional value to our clients for over 35 years.

Promedica International

Company Details